All Vaccinology articles – Page 10
-
NewsMeta-analysis: COVID-19 vaccination during pregnancy is safe and beneficial for mother and infant
Vaccination is associated with better neonatal outcomes without added maternal risk, according to research presented during the American Academy of Pediatrics 2025 National Conference & Exhibition.
-
NewsCholera vaccination campaign launched in Darfur to protect over 1.8 million people
A cholera vaccination campaign kicked off on 21 September 2025 in South Darfur, marking the start of a campaign that aims to reach 1.86 million people aged one year and older with oral vaccines in response to the ongoing outbreak.
-
NewsNew single-dose, temperature-stable rabies vaccines could expand global access
Researchers have discovered a new way to make human rabies vaccines that could greatly expand access to immunization across the globe. The new method creates shots that are temperature-stable—meaning they don’t need to be stored at cold temperatures.
-
NewsTropical diseases: Global health meeting showcases resilience of field under fire
At a moment of monumental challenges for global health, thousands of researchers, clinicians and public health professionals from over 100 countries will gather in Toronto for the 2025 Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).
-
NewsGut punch: $2 million to decode bacteria’s role in fighting disease
A $2 million grant to UC Riverside will explore how gut bacteria shape human health. The NIH award will support Ansel Hsiao’s lab in its quest to answer questions about how gut microbes communicate with each other and with their human hosts to influence health.
-
NewsCattle vaccine immunity ‘boost’ tested by new research
Scientists at Aberystwyth University are leading research into how a widely used vaccine can boost overall immunity in livestock. The four-year study will investigate the concept of ‘trained immunity’ – a form of immune memory triggered by a vaccine.
-
NewsNIH grant aims for childhood vaccine against HIV
A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine. Source: NIAID Transmission electron micrograph ...
-
CareersMeet the Advisory Groups: Our Q&A with Sharad Kamble
The Microbiologist chats with AMI’s Food Security Advisory Group member Sharad Kamble.
-
NewsAdverse event profiles following HPV vaccination in males
The safety profile among male recipients of human papillomavirus (HPV) vaccination remains a critical evidence gap. A new study presents the first systematic safety evaluation of Gardasil 9 and Gardasil in male recipients.
-
NewsScientists identify four ways our bodies respond to COVID-19 vaccines
Researchers tracked individuals’ antibody levels after vaccinations and identified four distinct patterns of immune response after the first booster, suggesting that monitoring how antibody levels change over time could assist in identifying individuals at greater risk of infection.
-
NewsScientists link waning Japanese encephalitis immunity to higher dengue severity
Scientists have found that waning immunity to Japanese encephalitis virus (JEV) may increase the risk of more severe dengue disease in humans. The study highlights how fading vaccine protection from one virus can unintentionally affect the body’s response to another.
-
NewsMost Americans favor MMR vaccine requirement for public school, survey finds
Research in April 2025 finds that 70% of the US public supports vaccine requirements for MMR (measles, mumps, and rubella) for children to attend public school, more than in 2023.
-
NewsWorld-first koala chlamydia vaccine approved
In a world first, a vaccine has been approved to protect Australia’s endangered koalas from infection and death caused by chlamydia.
-
NewsStudy reveals how dengue rewires the immune system, reshaping vaccine response
Just as a computer’s operating system can be rewritten after a major update, dengue infection can ‘re-programme’ the body’s immune system, leaving a long-lasting genetic imprint that influences how people respond to future infections—an effect not seen with vaccination.
-
NewsProtein discovery gives new hope for longer COVID protection
Scientists have discovered that the body’s immune system strongly reacts to an internal protein from SARS-CoV-2, the virus that causes COVID-19, which mutates less frequently than the surface-spike protein currently targeted by vaccines.
-
NewsStudy suggests link between hepatitis B immunity and lower risk of developing diabetes
A research study shows that overall HBV immunity is linked with a 15% lower risk of diabetes, with higher protection in younger people and those with higher immunity shown by higher antibody levels.
-
NewsOne shot of RSV vaccine effective against hospitalization in older adults for two seasons
One shot of an RSV vaccine protects adults ages 60 or older from RSV-associated hospitalization and critical illness during two consecutive RSV seasons, according to a new study.
-
NewsPertussis resurgence in Tuscany outlines importance of timely vaccination in Italy
Research analysing 2016-2024 data from all pertussis-related hospitalisations in Tuscany, Italy, finds a ninefold increase in pertussis cases in 2024 among children and adolescents.
-
NewsSeroprevalence 36 months after a single-dose bivalent HPV vaccination among nine to fifteen-year-old girls
A single-dose bivalent HPV vaccine induces sustained immunity in Bangladeshi adolescent girls, with lower HPV16 seropositivity among older girls and those in higher grades, with higher HPV18 seropositivity linked to lower household income.
-
NewsNew African swine fever vaccine candidate shows promise against some virus strains
An international team of scientists has found that a promising African swine fever (ASF) vaccine can protect pigs against some strains of the virus but offers little or no protection against others.